Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $79.5600 (-0.97%) ($78.0000 - $82.7800) on Thu. May. 24, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3% (three month average) | RSI | 29 | Latest Price | $79.5600(-0.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -1.5% a day on average for past five trading days. | Weekly Trend | SONN declines -5.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) QQQ(19%) SDY(19%) SKYY(19%) XAR(19%) IBB(18%) | Factors Impacting SONN price | SONN will decline at least -1.5% in a week (0% probabilities). VCSH(-30%) LQD(-22%) TLT(-21%) CEMB(-20%) DIA(-17%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.5% (StdDev 3%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
1 - 5 Day Possible Target | $73.48(-7.64%) | Resistance Level | $86.08 | 5 Day Moving Average | $80.44(-1.09%) | 10 Day Moving Average | $82.96(-4.1%) | 20 Day Moving Average | $86.08(-7.57%) | To recent high | -19.3% | To recent low | 0.3% | Market Cap | $732m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |